Live Breaking News & Updates on National Principal Investigator

Stay updated with breaking news from National principal investigator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study

Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Amar Sawhney , Nadine Abi Jaoudeh , Prnewswire Instylla Inc , Instylla Inc , National Principal Investigator , University Of California , Tumor Pivotal , Tumor Pivotal Study , Hydrogel Embolic System , Interventional Radiology , Managing Director , Embrace Hydrogel Embolic System ,

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , Scott Kasner , Thomas Flaten , Scott Kellen , Rick Pauls , Diamedica Therapeutics Inc , High School Dropout , Health Canada , Australian Stroke Alliance , University Of Pennsylvania , Canadian Stroke Consortium , National Principal Investigator , Canadian Stroke Alliance , Diamedica Therapeutics , Call Transcript May , Medica Therapeutics , Diamedica Therapeutics First Quarter , Investor Relations , Cautionary Statement Note , Risk Factors , Chief Executive , Lorianne Masuoka , Chief Medical Officer , Chief Financial , Tampa General Hospital , Rebekah Fries ,

Bio-Path Holdings (BPTH) Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients

Bio-Path Holdings (BPTH) Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , David Hermel , Gailj Roboz , Gary Schiller , Maro Ohanian , Peter Nielsen , Path Holdings , National Principal Investigator For The Phase , University Of Texas Md Anderson Cancer Center , Translational Leukemia Program , Drug Administration , Scripps Health , Department Of Leukemia , Path Holdings Inc , Weill Medical College Of Cornell University , Bio Path Holdings , United States Food , Chief Executive Officer , Weill Medical College , Cornell University , Cancer Center , Los Angeles Cancer , National Principal Investigator , New York Presbyterian Hospital , Los Angeles Cancer Center ,

VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial ....

United States , Geoffrey Lucks , Eric Peden , Hala Barakat , Jenniferl Horspool , Timothy Boire , Jason Burgess , Tim Boire , Venostent Selfwrap Bioabsorbable Perivascular , Mark Barakat , Clinical Affairs Mark Barakat , News Network , Clinical Affairs , Venostent Inc , National Science Foundation , Breakthrough Technology , National Principal Investigator , National Institute Of Health , Venostent Co , Stent Enrolls First Subjects , Fistulas Clinical Trial , Surgical Specialists , Vascular Surgeons , Selfwrap Bioabsorbable Perivascular Wrap , Venostent Director , Project Coordinator Hala Barakat ,

DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference

DiaMedica Presents the Protocol and Rationale for ReMEDy2, a Pivotal Trial in Patients Suffering Acute Ischemic Stroke Ineligible for tPA and/or Mechanical Thrombectomy

. ....

United States , Scott Kasner , National Principal Investigator , International Stroke Conference , American Heart Association , Diamedica Therapeutics Inc , Diamedica Therapeutics , Stroke Conference , Treatment Of Acute Ischemic Stroke , Poster Hall , Poster Board , Thursday February , Medica Therapeutics ,